Neurosurgeon: My Patients Show Me Real Heroism and Resilience
March 11, 2024
UC San Diego Health provides the most advanced neurological cancer care by combining leading-edge surgical techniques and the latest technology.
Your search for “immunotherapy” returned 120 results
Preclinical Data Shows Combination Immunotherapy Could Stop Liver Cancer Growth
March 13, 2019
New preclinical data from University of California San Diego School of Medicine and Moores Cancer Center offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.
Three Entrepreneurial UC San Diego Faculty Members To Join National Academy of Inventors
December 8, 2022
UC San Diego’s ranks now include 18 fellows of the National Academy of Inventors. Three professors have been named 2022 NAI fellows, the highest professional distinction awarded to academic inventors.
CIRM Approves $5.8 Million Grant for CAR-T Therapy that Targets Cancer Stem Cells
July 20, 2017
…Diego School of Medicine researchers to develop a new immunotherapy in which patients’ cells would be equipped with a special receptor that recognizes and targets cancer stem cells, whose survival abilities often render standard therapies ineffective or short-term.
SPARK Gala Returns April 25 to Support Cancer Research and Care
April 22, 2015
San Diego community members, physicians and cancer survivors will come together Saturday, April 25 at the Grand Del Mar for SPARK Gala, an evening to “ignite the fight against cancer.”
New Cancer Immunotherapy Approach Turns Immune Cells into Tiny Anti-Tumor Drug Factories
December 4, 2018
In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs.
Philanthropists Ignite the Fight Against Cancer at SPARK Gala April 16
April 12, 2016
To rally the San Diego region in the fight against cancer, the University of California San Diego’s Moores Cancer Center will host its annual SPARK Gala on Saturday, April 16 at the Fairmont Grand Del Mar. The evening will include a three-course dinner with wine pairings, a live luxury auction…
Ultrasound Remotely Triggers Immune Cells to Attack Tumors in Mice Without Toxic Side Effects
August 12, 2021
A new cancer immunotherapy pairs ultrasound with cancer-killing immune cells to destroy malignant tumors while sparing normal tissue. The approach could make chimeric antigen receptor (CAR) T-cell therapy safer and effective at treating solid tumors.
Study: Immunotherapy Better than Chemotherapy for Subtype of Head and Neck Cancer
November 30, 2018
A randomized clinical trial involving 97 medical centers in 20 countries, including Moores Cancer Center at UC San Diego Health, found that treating patients with head and neck cancer with the immunotherapy drug pembrolizumab is more effective and less toxic than standard chemotherapy.
Nanoparticle Vaccine Could Curb Cancer Metastasis to Lungs by Targeting a Protein
October 18, 2023
UC San Diego engineers have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs. Its success lies in targeting a protein known to play a central role in cancer growth and spread, rather than targeting the primary tumor itself.
